NEW YORK - Restaurants in New York are adjusting to the rise of appetite-suppressing weight-loss drugs like Ozempic by offering smaller, cheaper meals.
Manhattan’s Le Petit Village has introduced reduced portions on its brunch menu, catering to diners on GLP-1 medications who still want to eat out but can’t manage large servings.
About one in eight American adults are currently taking GLP-1 drugs, according to a November KFF poll, with one in five saying they’ve used medications like Ozempic or Wegovy at some point.
Other eateries are following suit. Clinton Hall owner Aristotle Hatzigeorgiou said he noticed customers eating far less, leading to food waste. He introduced an $8 “mini-meal” — a small burger, fries and a drink — which has proved popular with both weight-loss patients and cost-conscious diners.
Experts say wider use of GLP-1 drugs could reshape how people relate to food, though the long-term effects remain unclear. Some see the shift toward smaller portions as a healthy correction after decades of oversized meals.